Openbookopenbook
Equity
Cansortium Inc(CNTMF)
USD --+0.00%
Reward60Moderate
Risk73High
📊75%Data
Thin -55% profit margin
CNTMF
+0.0 · +0.00%
USD · OTCQB
Cansortium Inc | Healthcare
Value Trap
Market Cap:25.49M
ℹ️
Reward Rating
60
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
73
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on CNTMF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $1.70.

What is Cansortium Inc?

, through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

CNTMF · Verdict

Solid reward · high risk

CNTMF stands out on valuation and growth, but watch the balance sheet signal.

Based on 88% data coverage

CNTMF · Verdict

What’s working & what to watch

Strengths 2

  • Valuation89/100

    P/E 1.4×

  • Growth70/100

    Rev +16.5% CAGR · earnings +28.5%

Watchouts 3

  • Balance sheet18/100

    Current ratio 0.86

  • Cash flow22/100

    -15% free-cash-flow margin

  • Profitability31/100

    -39% net margin · -534% ROE

Model-based scoring. For information only — not financial advice.

What is Cansortium Inc?

, through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, edibles, and other accessories under the Fluent brand name. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 25.49M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (60)

The scoring profile indicates moderate reward potential, with valuation and growth as the leading contributors. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap25.49M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.09
52 Week Low0.027
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding613M
No. of Employees826
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTCQB
Beta0.827
CurrencyUSD
Websiteinvestors.getfluent.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.